Venous Thromboembolism Risk Assessment and Thromboprophylaxis Practice in Nonorthopedic Hospitalized Surgical Patients: A Singapore's Perspective, Part 3: Is the Rate of Asian VTE as Low as Perceived?

Abstract

Venous thromboembolism (VTE) remains a leading cause of preventable hospital mortality. Despite clear guidelines on risk assessment and prophylaxis, adherence varies worldwide. This study evaluated the perceptions and practices of VTE risk assessment and thromboprophylaxis among surgeons managing nonorthopedic hospitalized surgical patients in Singapore. A cross-sectional, anonymous online survey was conducted among consultant-grade surgeons across three public hospitals. The survey assessed perceptions of VTE incidence, use of risk assessment tools, and prophylaxis practices. Responses were analyzed by seniority, subspecialty, and training background. Forty-five surgeons responded: 35.5% were senior consultants, 48.9% consultants, and 15.5% associate consultants. 51.1% of the respondents routinely performed VTE risk assessments, while 68.9% routinely prescribed thromboprophylaxis. Senior consultants were less likely to perform formal risk assessments (31.3%) compared with associate consultants (71.4%) but more likely to prescribe prophylaxis. A perceived low incidence of VTE in Singapore (59.0%) was a key reason for omitting assessment. Prophylaxis was driven by perceived high patient risk (29.0%) and guideline adherence (38.7%). Most respondents (84.4%) supported routine assessment and prophylaxis. Suggested interventions included national guidelines, EMR-based tools, and continuing medical education. Uptake of VTE risk assessment and prophylaxis is moderate, with variability linked to seniority and training. The belief that VTE risk is low in Asian populations remains a barrier, despite rising incidence. National guidelines, EMR integration, and education may improve adherence and reduce preventable VTE events.

Keywords

DVT - VTE - prophylaxis - nonorthopedic - surgical - risk assessment - vascular - vascular surgery

Publikationsverlauf

Eingereicht: 16. Juni 2025

Angenommen: 29. September 2025

Artikel online veröffentlicht:
23. Oktober 2025

• References

• 1 Lee C-H, Lin L-J, Cheng C-L, Kao Yang Y-H, Chen J-Y, Tsai L-M. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost 2010; 8 (07) 1515-1523
• 2 Yeo DXW, Junnarkar S, Balasubramaniam S. et al. Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients: a systematic review. World J Surg 2015; 39 (01) 150-157
• 3 Liew NC, Alemany GV, Angchaisuksiri P. et al. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Int Angiol 2017; 36 (01) 1-20
• 4 Er C, Kuthiah N, Adamjee T, Tay JC. Venous thromboembolism risk assessment and thromboprophylaxis practice in general medical patients requiring admissions to general wards: a Singapore's perspective. Int J Angiol 2021; 30 (04) 299-304
• 5 Er C, Kuthiah N, Adamjee T, Tay JC. Venous thromboembolism risk assessment and thromboprophylaxis practice in general medical patients requiring admissions to general wards: a Singapore's perspective, part 2. Int J Angiol 2021; 32 (02) 146-152
• 6 DMaran ES, Er C, Gohar S, Adamjee T. Preventable hospital admission-associated VTE: thoughts on thromboprophylaxis as Asians. Int J Angiol 2024; 34 (01) 78-81
• 7 Lee SY, Er C. Venous thromboembolism risk assessment and thromboprophylaxis practice in hospitalized medical patients: the experience of a Singapore teaching hospital. Int J Angiol 2024; 34 (01) 75-77
• 8 Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ) 2001; 43 (43) i-x , 1–668
• 9 Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost 2017; 117 (12) 2243-2260
• 10 Wee Ming T, Ts G, Lt T. Incidence of venous thromboembolism in Asian trauma patients - an Asian trauma centre review. Int J Crit Care Emerg Med 2018; 4 (02)
• 11 Mao W, Lim JXY, Tan JH, Chang SM, Hong CC. Prevalence and risk factors of symptomatic venous thromboembolism in distal femur fractures. Singapore Med J 2024;
• 12 PMO | PM Lee Hsien Loong at the ‘Singapore Ageing: Issues and Challenges Ahead’ Book Launch. Accessed March 30, 2025 at: https://www.pmo.gov.sg/Newsroom/PM-Lee-Hsien-Loong-at-the-Singapore-Ageing-Issues-and-Challenges-Ahead-Book-Launch
• 13 Wang X, Wang J, Zhang X. et al. Trends of hospital-acquired lower extremity deep venous thrombosis in an academic medical center in China from 2007 to 2021. Ann Vasc Surg 2025; 115: 3-12
• 14 Angchaisuksiri P, Goto S, Farjat AE. et al. Venous thromboembolism in Asia and worldwide: emerging insights from GARFIELD-VTE. Thromb Res 2021; 201: 63-72
• 15 Khan MI, O'Leary C, Silvari V. et al. Venous thromboembolism - risk assessment tool and thromboprophylaxis policy: a national survey. Ir Med J 2017; 110 (01) 499
• 16 Agency for Clinical Effectiveness. Venous thromboembolism—treating with the appropriate anticoagulant and duration. ACE Clinical Guidance (ACG), Ministry of Health, Singapore. Accessed 2024 at: go.gov.sg/acg-venous-thromboembolism-treatmen
• 17 Gould MK, Garcia DA, Wren SM. et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (02) e227S-e277S
• 18 Overview | Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | Guidance | NICE. Accessed March 31, 2025. https://www.nice.org.uk/guidance/ng89
• 19 Pannucci CJ, Swistun L, MacDonald JK, Henke PK, Brooke BS. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a meta-analysis. Ann Surg 2017; 265 (06) 1094-1103
• 20 Ma SG, Yang Y, Huang Y. Venous thromboembolism risk assessment scale for prediction of venous thromboembolism in inpatients with cancer: a meta-analysis. Thromb Res 2024; 240: 109058
• 21 Er C, Cohen AT. Limitations of venous thromboembolism risk assessment models in medical patients: response to “unmet definitions in thromboprophylaxis for hospitalized medical patients: an appraisal for the need of recommendation.”. Res Pract Thromb Haemost 2023; 7 (01) 100027
• 22 Zhang Z, Zhen K, Li W. et al; DissolVE-2 investigators. Validation of the IMPROVE bleeding risk assessment model in surgical patients: results from the Dissolve-2 study. Thromb Res 2023; 223: 69-77
• 23 Tsaftaridis N, Goldin M, Spyropoulos AC. System-wide thromboprophylaxis interventions for hospitalized patients at risk of venous thromboembolism: focus on cross-platform clinical decision support. J Clin Med 2024; 13 (07) 2133